Isotretinoin for acne vulgaris

International Journal of Dermatology

Volumn 35, Issue 3, 1996, Pages 212-215

  Al Khawajah, Marwan M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHEILITIS; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 0029921171     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb01645.x     Document Type: Article

References (35)

1. Peck GL, Olsen TG, Yoder FW, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979; 300:329-333.
2. Peck GL, Olsen TG, Butkus D, et al. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol 1982; 6: 735-745.
3. Windhorst DB, Nigra T. General clinical toxicology of oral retinoids. J Am Acad Dermatol 1982; 6:675-682.
4. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10:490-496.
5. Shalita AR, Armstrong RB, Leyden JJ, et al. Isotretinoin revisited. Cutis 1988; 42:1-19.
6. Wolverton SE. Retinoids. In: Wolverton SE, Wilkin JK, eds. Systemic drugs for skin diseases. Philadelphia: WB Saunders, 1991:191-218.
7. Peck GL, DiGiovanna JJ. Retinoids. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Dermatology in general medicine. 4th Ed. New York: McGraw Hill, 1993: 2883-2908.
8. Yob EH, Pochi PE. Side effects and long-term toxicity of synthetic retinoids. Arch Dermatol 1987; 123:1375-1378.
9. Bigby M, Stern RS. Adverse reactions to isotretinoin. J Am Acad Dermatol 1988; 18:543-552.
10. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27: S23-S28.
11. Breathnach SM. Drug reactions. In: Champion RH, Burton JL, Ebling FG, eds. Textbook of dermatology. 5th Ed. Oxford: Blackwell Scientific, 1992:3015-3107.
12. Hogan DL, Strand LM, Lane PR. Isotretinoin therapy for acne: a population-based study. Can Med Assoc J 1988; 138:47-50.
13. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992; 27: S2-S7.
14. Chivot M, Midoune H. Isotretinoin and acne: a study of relapses. Dermatologica 1990; 180:240-243.
15. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313:837-841.
16. Lehuchen-Ceyrac D, Serfaty D, Lefrancq H. Retinoid and contraception. Dermatology 1992; 184:210-213.
17. Vahlquist A. Long-term safety of retinoid therapy. J Am Acad Dermatol 1992; 27:529-533.
18. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129:292-296.
19. Shahidullah M, Tham SN, Goh C-L. Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore. Int J Dermatol 1994; 33:60-63.
20. Harms M, Masouye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica 1986; 172:148-153.
21. Stainforth JM, Layton AM, Taylor JP, et al. Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 1993; 129:297-301.
22. Layton AM, Stainforth JM, Cunliffe WJ. Ten years' experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatol Treat 1993; 4:(Suppl 2):S2-S5.
23. Lafange H, Levy PE. Evaluation économique d'une innovation médicamenteuse: le traitement de l'acne sevère par Roaccutane. J Econ Med 1987; 5:117-127.
24. Cunliffe WJ, Gray JA, MacDonald HS, et al. Cost effectiveness of isotretinoin. J Dermatol Treat 1991; 1:285-288.
25. Pochi PE, Shalita AR, Strauss JS, et al. Report of the consensus conference on acne classification. J Am Acad Dermatol 1991; 24:495-500.
26. David M, Hodak E, Lowe NJ. Adverse effects of retinoids. Med Toxicol 1988; 3:273-288.
27. Michaelsson G, Vahlquist A, Mobaeken H, et al. Changes in laboratory variables induced by isotretinoin treatment of acne. Acta Derm Venereol (Stockh) 1986; 66:144-148.
28. Ginsberg H, Rubenstein A, Brown WV. Medical complications of isotretinoin. Clin Dermatol 1986, 4:183-189.
29. Lowe NJ, David M. New retinoids for dermatologic diseases. Dermatol Clin 1988; 6:539-552.
30. Roenigk HH Jr. Liver toxicity of retinoid therapy. Pharmacol Ther 1989; 40:145-155.
31. Zachariae H, Foged E, Bjerring P, et al. Liver biopsy during etretinate (Tigason) treatment. In: Saurat JH, ed. Retinoids: new trends in research and therapy. Basel: Kraeger, 1985:494-497.
32. Lewis B. Hyperlipidemia. In: Chen RD, Lewis B, Alberti KGM, et al., eds. The metabolic and molecular basis of acquired disease. London: Baillière Tindall, 1990:887-997.
33. Shalita AR. Lipid and teratogenic effects of retinoids. J Am Acad Dermatol 1988; 19:197-198.
34. Walker BR, Mackie RM. Serum lipid elevation during isotretinoin therapy for acne in the West of Scotland. Br J Dermatol 1990; 122:531-537.
35. Barth JH, MacDonald SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704-707.